Huntington’s disease blood biomarker identified

Written by Lauren Pulling, Editor

A collaborative study led by researchers at University College London (UK) has identified a biomarker for Huntington’s disease (HD). The findings, published in Lancet Neurology, demonstrate that neurofilament light chain circulating in the blood can be measured with a blood test, and is amplified both in HD patients and carriers of the disease. “This is the first time a potential blood biomarker has been identified to track HD so strongly,” said the study’s senior author, Edward Wild (UCL Institute of Neurology). While neurofilament has been previously linked to other neurodegenerative disorders, this is the first time it has been studied...

To view the full article, please register now for access

It's completely free